OPTH (Optimi Health) 3-1 Month Momentum %: N/A% (As of Jul. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OPTH Optimi Health Corp OPTH
25 GF Score
Price $4.96
GF Value $4.42
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Optimi Health 3-1 Month Momentum %?

Optimi Health OPTH +4.42% 25 3-1 Month Momentum % is N/A% as of Jul. 16, 2026. GuruFocus rates OPTH with a GF Score™ of 25/100 and a GF Value™ of $4.42 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 1,026 Drug Manufacturers companies, Optimi Health ranks worse than 79.43% on this metric.

3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-07-16), Optimi Health's 3-1 Month Momentum % is N/A%.

The industry rank for Optimi Health's 3-1 Month Momentum % or its related term are showing as below:

OPTH's 3-1 Month Momentum % is not ranked *
in the Drug Manufacturers industry.
Industry Median: -8.36
* Ranked among companies with meaningful 3-1 Month Momentum % only.

Optimi Health  (NAS:OPTH) 3-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.

Optimi Health 3-1 Month Momentum % Related Terms

OPTH
25GF Score
Optimi Health Corp OPTH
3-1 Month Momentum % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Optimi Health  (NAS:OPTH) 3-1 Month Momentum % Calculation

3-1 Month Momentum % is calculated as following:

3-1 Month Momentum %=( Price 1-month ago / Price 3-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 3-1 Month Momentum % →
What does a 3-1 Month Momentum % of N/A% mean?
Optimi Health (OPTH) has a 3-1 Month Momentum % of N/A% as of Jul. 16, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Optimi Health and its competitors. According to the industry distribution chart, Optimi Health ranks #815 out of 1026 companies in the Drug Manufacturers industry, placing it in the top 79.4%.
Is Optimi Health's 3-1 Month Momentum % too high?
Optimi Health's current 3-1 Month Momentum % is N/A%. Based on the distribution chart, Optimi Health ranks #815 out of 1026 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Optimi Health has a GF Score™ of 25/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Optimi Health's 3-1 Month Momentum % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Optimi Health ranks #815 out of 1026 companies for 3-1 Month Momentum %. This places Optimi Health in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Drug Manufacturers company?
A good 3-1 Month Momentum % depends on the Drug Manufacturers industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Optimi Health and its competitors. Optimi Health's current 3-1 Month Momentum % is N/A%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Optimi Health stock overvalued right now?
Based on GuruFocus' analysis, Optimi Health (OPTH) is currently considered Modestly Overvalued. The stock's GF Value™ is $4.42, compared to a current price of $4.96 — trading 12.2% above its estimated fair value. The current 3-1 Month Momentum % is N/A%. Optimi Health's overall GF Score™ is 25/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Optimi Health (OPTH), the current 3-1 Month Momentum % is N/A% as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Optimi Health (OPTH) Overvalued in 2026?

Based on GuruFocus' analysis, Optimi Health stock appears to be overvalued. The current stock price of $4.96 is trading 12.2% above its estimated GF Value™ of $4.42. GuruFocus considers Optimi Health to be Modestly Overvalued.

Key valuation signals for OPTH:

  • 3-1 Month Momentum %: N/A%
  • GF Value™: $4.42 vs. price of $4.96 (12.2% above fair value)
  • GF Score™: 25/100 with 4 warning signs

No single metric tells the full story. See the OPTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Optimi Health Business Description

Other Exchanges 8BN0:GermanyOPTI:Canada
Address 269 David Brown Way, Po Box 728, Princeton, BC, CAN, V0X 1W0
Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing, and distribution of raw mushroom biomass. It also intends to cultivate, extract, process, and distribute strains of fungi products at its facilities located in Princeton, British Columbia.
25GF Score

Get the complete analysis for OPTH

3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.96
Price
$4.42
GF Value